Featured
In the News
Subscription Required
December 20, 2021
34 healthcare and biotech startups that are set to take off in 2022, according to top investors
December 20, 2021
December 20, 2021
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
December 20, 2021
December 20, 2021
Mental health startup Cerebral teams with Alto Neuroscience to bring 'precision psychiatry' to patients' homes
December 20, 2021
Subscription Required
December 20, 2021
Better treatments for brain disorders start with knowing what to treat
December 20, 2021
Subscription Required
October 15, 2021
From depression to sleep, new era of psychiatric drugs is here, says startup CEO
October 15, 2021
October 14, 2021
A star Stanford professor leaves his lab for a startup out to remake psychiatry
October 14, 2021
October 14, 2021
Alto Neuroscience Emerges From Stealth With $40M Aimed At Matching Patients And Drugs
October 14, 2021
Subscription Required
October 28, 2020
Biomarkers For PTSD And Depression Could Mean Personalized Treatment For Patients
October 28, 2020
February 19, 2020
How Artificial Intelligence Can Help Pick the Best Depression Treatments for You
February 19, 2020
February 10, 2020
Brain activity can help predict who'll benefit from an antidepressant
February 10, 2020
February 10, 2020
Will That Antidepressant Work For You? The Answer May Lie In Your Brain Waves
February 10, 2020
February 10, 2020
Brain scans could be used to identify who will benefit from antidepressants
February 10, 2020
Receive updates from Alto
Oops! Something went wrong while submitting the form.